Cite
MLA Citation
B Fautrel et al.. “AB0395 Subcutaneous tocilizumab as monotherapy or in combination with a csdmard in patients with rheumatoid arthritis: 24 weeks results of the french phase iiib study, "tosca".” Annals of the rheumatic diseases, vol. 76, n.d., pp. 1186–1187. http://access.bl.uk/ark:/81055/vdc_100135134646.0x00005e